Epicore Biosystems
Series B in 2025
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
Epicore Biosystems
Series A in 2022
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
IDUN Technologies
Seed Round in 2021
IDUN Technologies AG, established in 2017 and based in Opfikon, Switzerland, specializes in designing and manufacturing biosensors for wearable devices. The company's primary product is DRYODES, a line of dry conductive electrodes used for bio-potential monitoring, including ECG, EEG, and EMG applications. IDUN's innovative bioinspired surfaces enable natural adhesion without adhesives or stickers, making its products suitable for consumer applications and brain-computer interfaces. The company's vision is to use in-ear EEGs to create a more connected world by providing real-time neuro marker measurements through its Guardian Neuro-Intelligence Platform. IDUN integrates neuroscience into everyday product designs, enabling connected devices to understand users' emotional needs better, thereby enhancing product experiences.
Sharper Sense
Seed Round in 2021
Sharper Sense is a company that specializes in wearable neurotechnology designed to enhance sensory acuity, specifically vision, hearing, and touch. The firm has developed a neuromodulation patch that utilizes noninvasive electrical stimulation to improve sensory processing. This innovative technology has both clinical and commercial applications, including the treatment of sensory processing disorders and sensory loss. By providing users with clearer and more accurate perceptions, Sharper Sense aims to enhance performance and safety in various environments, ultimately improving the overall sensory experience.
Zone7 is a company that specializes in artificial intelligence-based software designed to predict sports injuries and optimize athletic performance. Founded in 2017 and headquartered in Palo Alto, California, Zone7 collects and analyzes data from various sources, including wearable devices, medical records, and fitness profiles. The software aims to identify injury risks before they occur, enabling coaching staff and medical professionals to make informed decisions regarding training, rest, and work assignments. Zone7's technology is utilized by over 30 professional sports franchises and is also applied in hospitals to monitor the well-being of medical staff. By providing actionable insights, Zone7 enhances the health, potential, and durability of athletes and the elite workforce, ultimately aiming to improve human performance across various fields.
Nanoleq
Venture Round in 2021
Nanoleq AG is a Swiss company founded in 2017 and based in Zurich, specializing in the development and manufacture of electric cables utilizing stretchable electronics. As a spinoff from ETH Zurich, Nanoleq focuses on integrating electronic functionality into textiles, particularly for health monitoring. The company creates soft sensors that can track vital signs such as heart rate, electrocardiograms, and breathing patterns through washable and comfortable garments. Their innovative conductive silicone technology allows for the monitoring of various physiological parameters while maintaining user comfort. Nanoleq aims to establish a standard for health-monitoring textiles, making significant strides in sectors such as healthcare, robotics, aerospace, and general electronics, while also working on further advancements in textile sensor technology.
Zone7
Venture Round in 2020
Zone7 is a company that specializes in artificial intelligence-based software designed to predict sports injuries and optimize athletic performance. Founded in 2017 and headquartered in Palo Alto, California, Zone7 collects and analyzes data from various sources, including wearable devices, medical records, and fitness profiles. The software aims to identify injury risks before they occur, enabling coaching staff and medical professionals to make informed decisions regarding training, rest, and work assignments. Zone7's technology is utilized by over 30 professional sports franchises and is also applied in hospitals to monitor the well-being of medical staff. By providing actionable insights, Zone7 enhances the health, potential, and durability of athletes and the elite workforce, ultimately aiming to improve human performance across various fields.
Nanoleq
Convertible Note in 2020
Nanoleq AG is a Swiss company founded in 2017 and based in Zurich, specializing in the development and manufacture of electric cables utilizing stretchable electronics. As a spinoff from ETH Zurich, Nanoleq focuses on integrating electronic functionality into textiles, particularly for health monitoring. The company creates soft sensors that can track vital signs such as heart rate, electrocardiograms, and breathing patterns through washable and comfortable garments. Their innovative conductive silicone technology allows for the monitoring of various physiological parameters while maintaining user comfort. Nanoleq aims to establish a standard for health-monitoring textiles, making significant strides in sectors such as healthcare, robotics, aerospace, and general electronics, while also working on further advancements in textile sensor technology.
Oga is developing an interactive fitness platform that aims to create a fully immersive workout experience. Utilizing advanced technology, Oga tracks and analyzes the movements of users through any device's camera, providing real-time feedback that simulates the experience of a personal workout studio. The platform allows individuals to participate in live sessions with trainers, enhancing the motivation and engagement typically found in in-person classes. By monitoring 18 joints of the human body, Oga's motion comparison technology ensures that users receive accurate guidance on their movements, enabling them to exercise effectively anytime and anywhere.
Feebris
Funding Round in 2020
Feebris Ltd is a UK-based company, founded in 2017 and headquartered in Saffron Walden, that specializes in developing artificial intelligence and machine learning algorithms for the detection of respiratory conditions. The company creates a mobile software platform that integrates with various point-of-care devices, such as digital stethoscopes and wearables. This technology is designed for community-based diagnosis and monitoring, allowing non-clinical users to identify early signs of deterioration in patients, thereby preventing complications and reducing the need for hospitalization. Feebris' team comprises experts in biomedical engineering, machine learning, global health, and business, all dedicated to transforming healthcare into a more equitable, personalized, and patient-driven system.
Noctrix Health
Funding Round in 2020
Noctrix Health, Inc. is an early-stage medical device company founded in 2018 and based in Menlo Park, California. The company specializes in developing therapeutic wearable devices aimed at treating chronic neurological and sleep disorders, particularly focusing on conditions such as restless leg syndrome. Noctrix Health's innovative devices leverage neural circuitry to alleviate symptoms, promoting undisturbed sleep and allowing patients to manage their chronic medical conditions more effectively.
H2L Inc. is a Tokyo-based company focused on researching and developing electric stimulation devices that enhance human interaction with virtual environments. Founded in 2012, H2L creates innovative technologies aimed at expanding human capabilities. Its flagship products include UnlimitedHand, a virtual reality gaming controller that utilizes electronic muscle stimulation to interpret hand gestures and enable users to interact with virtual objects, and PossessedHand, a device equipped with a forearm belt that stimulates the muscles to control finger movements for applications in rehabilitation and learning support. The company aims to enrich user experiences in virtual and augmented reality by providing tactile feedback and measuring muscle movements, allowing users to engage more fully with digital experiences.
Embr Labs
Series B in 2019
Embr Labs Inc. is a thermal wellness technology company based in Somerville, Massachusetts, that specializes in developing and selling wearable devices designed to adjust body temperature for enhanced comfort. Originally founded as Wristify Inc. in 2014, the company rebranded in 2015. Embr Labs leverages patented technology to utilize thermal sensations as a means to influence the autonomic nervous system, aiding individuals in managing conditions such as hot flashes, sleep disturbances, and anxiety. The company's innovative approach combines thermal stimulation with digital interventions through a mobile app and cloud infrastructure, creating a comprehensive platform for users. With tens of thousands of customers across 170 countries, Embr Labs has recorded over 100 million minutes of thermal interventions. The technology was conceived by its founders while they were engineering students at MIT, and the company has received significant backing from various investors and grants.
Limbic
Convertible Note in 2019
Limbic is a London-based company founded in 2017 that specializes in developing innovative solutions for mental healthcare. The company creates an AI-enabled platform and software development kit (SDK) that measures heart rates through wearable devices, such as the Apple Watch, to assess users' emotional states. By leveraging machine learning, Limbic aims to enhance psychological therapy by providing insights into patients' mental health conditions. Additionally, the company offers medical devices that facilitate referrals and clinical assessments, thereby supporting mental health professionals in delivering effective therapies. Limbic is committed to addressing the growing mental health crisis by providing scalable solutions that improve the well-being of individuals.
FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.
IrisVision
Seed Round in 2019
IrisVision is a leader in digital vision technologies, specializing in assistive devices for individuals with low vision. The company has created an innovative visual assistive headset that utilizes wearable virtual reality technology to enhance the sight of vision-impaired users. This device features a 12-megapixel camera and a 70-degree field of view on an LED display, allowing for a customizable visual experience tailored to individual needs. By enabling those with vision impairments, including patients with macular degeneration, to see clearly, IrisVision aims to empower them to regain independence and engage fully in their daily activities.
Neosensory
Series A in 2019
Neosensory, Inc. is a company that specializes in developing wearable devices aimed at enhancing sensory perception for individuals. Founded in 2015 and based in San Mateo, California, Neosensory offers products such as Buzz, which utilizes vision-to-touch sensory substitution technology to assist blind individuals. The company focuses on transmitting various data streams to the brain through the sense of touch, leveraging the skin's potential for information delivery. Their innovative approach includes building hearing assistive technology that allows users to perceive sound through vibrations on the skin. Neosensory also provides a companion application for its products, enhancing the user experience and accessibility of information.
Neurosity
Seed Round in 2018
Neurosity Inc. is a New York-based company founded in 2018 that specializes in developing thought-powered wearable devices aimed at enhancing human productivity and well-being. The company offers a brain-computer interface known as Notion, which harnesses brain wave data to help users, particularly programmers, improve their focus and concentration. By translating thoughts into actionable output, Neurosity's technology enables individuals to measure their brain activity and utilize personalized applications directly on the device. This innovative approach fosters an environment where users can optimize their cognitive abilities and create new experiences driven by their thoughts.
Embr Labs
Series A in 2018
Embr Labs Inc. is a thermal wellness technology company based in Somerville, Massachusetts, that specializes in developing and selling wearable devices designed to adjust body temperature for enhanced comfort. Originally founded as Wristify Inc. in 2014, the company rebranded in 2015. Embr Labs leverages patented technology to utilize thermal sensations as a means to influence the autonomic nervous system, aiding individuals in managing conditions such as hot flashes, sleep disturbances, and anxiety. The company's innovative approach combines thermal stimulation with digital interventions through a mobile app and cloud infrastructure, creating a comprehensive platform for users. With tens of thousands of customers across 170 countries, Embr Labs has recorded over 100 million minutes of thermal interventions. The technology was conceived by its founders while they were engineering students at MIT, and the company has received significant backing from various investors and grants.
Epicore Biosystems
Seed Round in 2018
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
Noctrix Health
Pre Seed Round in 2018
Noctrix Health, Inc. is an early-stage medical device company founded in 2018 and based in Menlo Park, California. The company specializes in developing therapeutic wearable devices aimed at treating chronic neurological and sleep disorders, particularly focusing on conditions such as restless leg syndrome. Noctrix Health's innovative devices leverage neural circuitry to alleviate symptoms, promoting undisturbed sleep and allowing patients to manage their chronic medical conditions more effectively.
Flux Biosciences
Seed Round in 2018
Flux Biosciences is a company that originated from Stanford University, leveraging technology initially developed for reading and writing computer hard drives to create advanced point-of-care in vitro medical diagnostics. Its portable biosensor platform allows for the measurement of various biomarkers found in blood, urine, or saliva, providing insights related to exercise, stress, fertility, and diet. The biosensors are designed to detect specific biomarkers through real-time interactions with magnetic nanoparticles, enabling the simultaneous measurement of multiple markers from a single sample. By integrating data from these measurements with sleep and activity information from wearable devices, Flux Biosciences aims to empower individuals to manage their health and lifestyle choices more effectively, making medical-grade diagnostics accessible and actionable within the home.
Neosensory
Convertible Note in 2018
Neosensory, Inc. is a company that specializes in developing wearable devices aimed at enhancing sensory perception for individuals. Founded in 2015 and based in San Mateo, California, Neosensory offers products such as Buzz, which utilizes vision-to-touch sensory substitution technology to assist blind individuals. The company focuses on transmitting various data streams to the brain through the sense of touch, leveraging the skin's potential for information delivery. Their innovative approach includes building hearing assistive technology that allows users to perceive sound through vibrations on the skin. Neosensory also provides a companion application for its products, enhancing the user experience and accessibility of information.